![Andrew Hamer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 850 833 $ in data 31/07/2026
Andrew Hamer is Chief Medical Officer, Head-Research & Development at Cardiol Therapeutics, Inc. since 2021.
Formerly, Dr. Hamer was Executive Director-Global Development at Amgen, Inc. from 2018 to 2021.
Dr. Hamer was Vice President-Medical Affairs at Capricor Therapeutics, Inc. from 2013 to 2015 and also held the position of Vice President-Medical Affairs at Capricor, Inc. Dr. Hamer completed undergraduate education at the University of Otago.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/12/2025 | 669.947 ( 0,58% ) | 850 833 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 29/03/2021 |
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/03/2021 |
| CAPRICOR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 30/07/2015 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Cardiol Therapeutics, Inc.
 Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
